Efficacy, safety and tolerability of ongoing statin plus ezetimibe versus doubling the ongoing statin dose in hypercholesterolemic Taiwanese patients: an open-label, randomized clinical trial

BACKGROUND: Reducing low-density lipoprotein cholesterol (LDL-C) is associated with reduced risk for major coronary events. Despite statin efficacy, a considerable proportion of statin-treated hypercholesterolemic patients fail to reach therapeutic LDL-C targets as defined by guidelines. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Chih-Chieh, Lai, Wen-Ter, Shih, Kuang-Chung, Lin, Tsung-Hsien, Lu, Chieh-Hua, Lai, Hung-Jen, Hanson, Mary E, Hwang, Juey-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3403927/
https://www.ncbi.nlm.nih.gov/pubmed/22621316
http://dx.doi.org/10.1186/1756-0500-5-251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3403927/
https://www.ncbi.nlm.nih.gov/pubmed/22621316
http://dx.doi.org/10.1186/1756-0500-5-251

Ejemplares similares